Variant report
Variant | rs34203322 |
---|---|
Chromosome Location | chr3:46436956-46436957 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:46422400-46438600 | Weak transcription | Psoas Muscle | Psoas |
2 | chr3:46425400-46441800 | Weak transcription | Stomach Mucosa | stomach |
3 | chr3:46425800-46446600 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
4 | chr3:46428000-46448400 | Weak transcription | Primary T cells from cord blood | blood |
5 | chr3:46432400-46438200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr3:46432600-46437400 | Enhancers | Placenta | Placenta |
7 | chr3:46433400-46437000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr3:46434200-46437800 | Enhancers | Fetal Intestine Large | intestine |
9 | chr3:46434400-46437200 | Enhancers | Hela-S3 | cervix |
10 | chr3:46434400-46438200 | Enhancers | Adipose Nuclei | Adipose |
11 | chr3:46434600-46437600 | Enhancers | Fetal Intestine Small | intestine |
12 | chr3:46434600-46438000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
13 | chr3:46434600-46438600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
14 | chr3:46435200-46439000 | Enhancers | Spleen | Spleen |
15 | chr3:46435400-46437400 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
16 | chr3:46435400-46438000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr3:46435400-46440800 | Weak transcription | Esophagus | oesophagus |
18 | chr3:46435600-46437400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
19 | chr3:46435600-46437400 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
20 | chr3:46435600-46437400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
21 | chr3:46435600-46439200 | Enhancers | Lung | lung |
22 | chr3:46435800-46438200 | Weak transcription | Right Atrium | heart |
23 | chr3:46436000-46437200 | Weak transcription | Brain Anterior Caudate | brain |
24 | chr3:46436000-46438400 | Weak transcription | Left Ventricle | heart |
25 | chr3:46436400-46437200 | Enhancers | K562 | blood |
26 | chr3:46436400-46438800 | Enhancers | Primary monocytes fromperipheralblood | blood |
27 | chr3:46436600-46437200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
28 | chr3:46436600-46437600 | Enhancers | HMEC | breast |
29 | chr3:46436600-46438600 | Weak transcription | Pancreas | Pancrea |
30 | chr3:46436600-46439000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
31 | chr3:46436600-46439200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
32 | chr3:46436800-46437000 | Bivalent Enhancer | Osteobl | bone |
33 | chr3:46436800-46437200 | Weak transcription | Dnd41 | blood |
34 | chr3:46436800-46437400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
35 | chr3:46436800-46437800 | Enhancers | HSMM | muscle |
36 | chr3:46436800-46438400 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
37 | chr3:46436800-46438400 | Enhancers | Fetal Thymus | thymus |
38 | chr3:46436800-46438600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |